Pancreatitis drug blocks SARS-CoV-2 activators in the upper respiratory tract
Camostat pancreatitis drug inhibits new SARS-CoV-2 inhibitors identified in the upper respiratory tract. There are no available treatments developed for the treatment of COVID-19. Reproduction of a…
